Skip to content
Open access

Clinical and Social Determinants of Guideline-Directed Medical Therapy Optimization in Heart Failure with Reduced Ejection Fraction

Nov 2026 · medRxiv · 0 citations
Medicine

TL;DR

In patients with HFrEF referred to Cardiology in a safety net tertiary care center, higher utilization of GDMT at 90 days was achieved in those who have diabetes mellitus, more frequent medical appointments, or lower serum eGFR, emphasizing the role of healthcare access and utilization.

Read PDF

Similar papers

Open access Oct 2026

Impact of higher comorbidity burden on guideline-directed medical therapy in patients with heart failure with reduced ejection fraction

Patients with a higher comorbidity burden less often used quadruple therapy and had a worse prognosis, as well as its association with clinical outcomes, according to a prespecified subanalysis of the TITRATE-HF registry.

J. J. N. Krabbe, M. I. Wilde, A. Mosterd et al. · 0 citations
Open access Oct 2026

Traditional cardiovascular risk factors and guideline-directed medical therapy profile in ACHD living with HFrEF. a national referral centre study

The majority of adults with congenital heart disease (ACHD) who develop heart failure present with preserved ejection fraction. Evidence regarding heart failure with reduced ejection fraction (HFrEF) in this population remains limited, particularly in low- and middle-income countries. The aim of this study...

G. Avalos, E. Garcia-Cruz, J. Sánchez Nieto et al. · 0 citations
Review Open access Oct 2026

Clinical profile, prognosis, and medical therapy of heart failure with mildly reduced ejection fraction in clinical practice

For 3 of 4 medication classes of guideline-directed medical therapy (GDMT), evidence is poor regarding benefit for those with heart failure with mildly-reduced ejection fraction (HFmrEF; defined as left ventricular ejection fraction 41-49%). Knowledge of how these medications are used in contemporary practice is...

J. Wasfy, E. Shults, S. Gustus et al. · 0 citations
Open access Oct 2026

Impact of age on implementation and tolerability of guideline-directed medical therapy in heart failure with reduced ejection fraction

The need for improved implementation strategies to optimize guideline-directed therapy and dosing levels in the ageing HFrEF population is highlighted, with use of GDMT associated with better clinical outcomes, also among older patients.

J. J. N. Krabbe, M. I. Wilde, W. L. Verloop et al. · 0 citations
Open access Oct 2026

Temporal and institutional differences in heart failure guideline adherence in Taiwan.

BACKGROUND Guideline-directed medical therapy (GDMT) improves outcomes in heart failure with reduced ejection fraction (HFrEF); however, variations in adherence to guidelines across hospitals and over time remain unknown. We used two Taiwanese national registries to investigate temporal and institutional differences in...

Hung-Yu Chang, Hsin-Ti Huang, Chung-Lieh Hung et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.